QualityStocksNewsBreaks Archives - Page 3 of 1594

WednesdayJul 15, 2026 1:30 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Reports Continued Strong Phosphate Assays at Murdock Mountain

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) reported additional positive assay results from drill hole MM26-9 at its wholly owned Murdock Mountain project in Elko County, Nevada. The company intersected the Upper Phosphate Zone with a weighted average grade of 10.73% P2O5 over a true thickness of 4.48 meters, supporting the continuity of phosphate mineralization across the target area. The hole also returned 8.18% P2O5 over 1.0 meter in the Lower Phosphate Zone, while drill hole MM26-10 is nearing completion approximately 1.5 kilometers…

WednesdayJul 15, 2026 10:54 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Semiconductor Equipment Makers Benefit from AI Infrastructure Expansion

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is featured in a new AINewsWire editorial examining how the AI infrastructure buildout is driving demand beyond chips to the precision automation, robotics and semiconductor production equipment needed to manufacture them. The editorial highlights the company's evaluation of a dual-region manufacturing expansion of up to 100,000 square feet across Taiwan and the U.S. with strategic partner Jiun Jiang Enterprise to support growing demand from semiconductor, advanced packaging and industrial automation customers. The editorial also discusses broader industry developments involving Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM), Applied Materials Inc. (NASDAQ: AMAT), Lam Research Corporation (NASDAQ: LRCX) and SPX Technologies Inc. (NYSE: SPXC), noting continued investment…

WednesdayJul 15, 2026 10:50 am

QualityStocksNewsBreaks – Nuvectis Pharma, Inc. (NASDAQ: NVCT) Prices $100 Million Public Offering

Nuvectis Pharma (NASDAQ: NVCT) announced the pricing of its previously announced underwritten public offering of 5 million shares of common stock at $20.00 per share, generating expected gross proceeds of approximately $100 million. The company also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 1, 2026, subject to customary closing conditions. Nuvectis said it intends to use the net proceeds to advance development of its NXP100, NXP200 and NXP900 programs, support future product candidates,…

WednesdayJul 15, 2026 10:42 am

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

Regentis Biomaterials (NYSE American: RGNT) announced it has received approval from the European Notified Body to manufacture GelrinC(R) using its next-generation solvent-free manufacturing process, a milestone that supports the product's planned commercial launch in Europe. The company said the new process increases production yield by approximately 400%, producing five times more product from the same manufacturing volume while improving manufacturing efficiency, scalability and occupational and environmental safety. Extensive clinical testing validated consistent product quality and clinical performance. GelrinC(R), which has already received CE Mark approval in Europe, is a proprietary, cell-free hydrogel implant designed to regenerate cartilage through a minimally invasive 10-minute procedure. Regentis said commercialization will be supported…

WednesdayJul 15, 2026 9:20 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Announces Aug. 1 Launch of XcellaraHeart Cardiovascular Wellness Supplement

BioAdaptives (OTC: BDPT) announced the upcoming commercial launch of XcellaraHeart(TM), a cardiovascular wellness supplement that combines the company's Xcellara(TM) stem/progenitor cell mobilization formula with Tanshinone IIA, a bioactive compound derived from Danshen root. The company said the Xcellara(TM) base is supported by a randomized, double-blind, placebo-controlled clinical trial that demonstrated an average 268.8% increase in circulating primitive stem/progenitor-type cells after four weeks, while Tanshinone IIA has been studied for its effects on the SDF-1α/CXCR4 signaling pathway associated with cellular trafficking and cardiovascular repair biology. XcellaraHeart(TM) is scheduled to be available for order beginning Aug. 1, 2026, with initial deliveries expected…

WednesdayJul 15, 2026 9:10 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Reports 31% Increase in Indicated Palladium Equivalent Resource at Skaergaard Project

Greenland Mines (NASDAQ: GRML) announced that independent consultant SLR Consulting (Canada) Ltd. has completed the first U.S. Securities and Exchange Commission S-K 1300-compliant Technical Report Summary for the Skaergaard project in southeast Greenland, featuring an updated 2026 Mineral Resource Estimate effective July 3, 2026. The estimate increased indicated contained palladium equivalent ("PdEq") metal by 31% to 15.0 million ounces, boosted indicated grade by 36% to 3.04 g/t PdEq and raised inferred contained PdEq metal by 24% to 17.49 million ounces compared with the project's 2022 resource estimate. The company said the upgraded resource reflects improved geological modeling and updated metal…

WednesdayJul 15, 2026 9:00 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) to Host Second Quarter 2026 Stakeholder Update Call Aug. 13

Beeline Holdings (NASDAQ: BLNE) the fast-growing digital mortgage platform, announced it will host a stakeholder update call to discuss its second-quarter 2026 results on Thursday, Aug. 13, 2026, at 5 p.m. ET. The call will be hosted by CEO Nick Liuzza and CFO Chris Moe, who will review the company's quarterly performance and provide updates on ongoing initiatives. To view the full press release, visit https://ibn.fm/xIt0e About Beeline Holdings, Inc. Beeline Holdings, Inc. is a technology-driven mortgage and title platform focused on simplifying home financing through digital innovation, artificial intelligence, and automation. The Company provides residential mortgage lending, title services, and…

TuesdayJul 14, 2026 3:24 pm

QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Strengthens Position in Audience Engagement with Winfinite and Filter Fan Cam

Zacks Investment Research recently initiated coverage of Versus Systems (NASDAQ: VS), citing the company’s progress in strengthening its financial performance and advancing its gamification and audience engagement platform. Zacks highlighted improved first-quarter 2026 results, including significantly reduced operating losses and positive operating cash flow, along with potential growth opportunities tied to an extension of Versus’ technology licensing relationship with ASPIS. The company’s Winfinite and Filter Fan Cam platforms combine interactive games, real-world rewards, and augmented reality experiences to help brands, sports organizations, and entertainment companies increase customer engagement across digital and live-event channels. With a growing international footprint and continued product…

TuesdayJul 14, 2026 2:45 pm

QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) Targets Next Generation of Space Infrastructure with Mantis Investment

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising. Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) has entered the growing space infrastructure sector with a $200,000 strategic equity investment in Mantis Space, a company developing what it describes as the world’s first orbital power grid. The investment reflects Planet Ventures’ strategy of providing public market investors with exposure to emerging private companies in high-growth industries. Mantis aims to enable satellites to receive wireless power in orbit, potentially reducing spacecraft size, weight and cost while supporting the expanding space economy. The move comes…

TuesdayJul 14, 2026 2:18 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in a recent article that discussed its advancement of its proprietary multiple sclerosis therapy candidate, LUCID-MS, which is designed to target demyelination and protection or restoration of myelin integrity. The company reported that Phase 1 clinical studies in healthy volunteers demonstrated a favorable safety profile and that the therapy was generally well tolerated, supporting advancement into patient-focused studies. In April 2026, Quantum BioPharma submitted an Investigational New Drug application to the U.S. Food and Drug Administration for LUCID-MS, paving the way…

Site Search

Company Search

Category: QualityStocksNewsBreaks